Atlas Trials

A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts

Clinical trial NCT00130325 · COMPLETED

Trial details

NCT number
NCT00130325
Sponsor
Medical Research Council Unit, The Gambia
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Tuberculosis
Start date
2004-10-01
Primary completion
2008-10-01
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.